SARAH PEDEN: Open Payments
NPI 1891306205 · WEST COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,548 in 98 payments from 34 companies in 2025. Trend: 2023 $702 · 2024 $1,020 · 2025 $2,548
Food & beverage: $2,548
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 12 | $407 |
| AstraZeneca Pharmaceuticals LP | 11 | $318 |
| ABBVIE INC. | 7 | $177 |
| Novartis Pharmaceuticals Corporation | 6 | $165 |
| SOBI, INC | 2 | $146 |
| Janssen Biotech, Inc. | 5 | $116 |
| GlaxoSmithKline, LLC. | 2 | $111 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $81 |
| PFIZER INC. | 4 | $80 |
| Genentech USA, Inc. | 3 | $71 |
Products named: KEYTRUDA, LYNPARZA, ELAHERE, LONSURF, SCEMBLIX, ERLEADA, IMBRUVICA, TAGRISSO.
Industry payments across SC — which companies pay providers there.
